|
Omnipen-nDrug - Omnipen-n The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Ampicillin Sodium
Strength -
EQ 250MG BASE/VIAL
Applicant -
WYETH AYERST
New Drug Application (NDA) Number -
062718
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Dec 16, 1986
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Wyeth Ayerst Laboratories
Omnipen-n
Omnipen-n Eq 250mg Base/vial Injectable; Injection
Ampicillin Sodium Eq 250mg Base/vial Injectable; Injection Ampicillin Sodium Eq 2gm Base/vial Injectable; Injection Ampicillin Sodium Eq 2gm Base/vial Injectable; Injection Ampicillin Sodium Eq 500mg Base/vial Injectable; Injection Omnipen-n Eq 125mg Base/vial Injectable; Injection Omnipen-n Eq 125mg Base/vial Injectable; Injection Omnipen-n Eq 1gm Base/vial Injectable; Injection Omnipen-n Eq 1gm Base/vial Injectable; Injection Omnipen-n Eq 250mg Base/vial Injectable; Injection NewDrugInformation |